1) streptokinase
[英][,streptəu'kaineis] [美][,strɛpto'kaɪ,nes]
链激酶
1.
Effect of intravenous thrombolytic therapy of streptokinase on early acute myocardial infarction;
链激酶静脉溶栓治疗早期急性心肌梗死疗效分析
2.
Efficacy of intravenous thrombolytlc therapy with low dose recombinant tissue-type plasminogen activator, urokinase and streptokinase in patients with acute myocardial infarction;
小剂量重组织型纤溶酶原激活剂与尿激酶、链激酶治疗急性心肌梗死疗效观察
3.
The efficacy and safety of thrombolytic therapy with recombinant streptokinase in patients with acute myocardial infarction;
重组链激酶治疗急性心肌梗死的疗效和安全性
2) Gene recombinant streptokinase
链激酶类
3) antistreptokinase(ASK)
抗链激酶
4) recombinant streptokinase
重组链激酶
1.
Experimental study of preventive effect of recombinant streptokinase on cerebral vasospasm after subarachnoid hemorrhage;
重组链激酶预防蛛网膜下腔出血后脑血管痉挛的实验研究
2.
Objective To evaluate the efficacy and safety of intravenous recombinant streptokinase (r-SK),produced in China,compared with urokinase (UK) in the treatment of acute myocardial infarction (AMI).
目的 观察国产重组链激酶 (r -SK )在急性心肌梗死 (AMI)静脉溶栓治疗中的临床疗效和不良反应 ,用尿激酶 (UK)作为对照 ,评价r -SK的安全性。
3.
Aim:Preventing patients with aneurysm from delayed cerebral vasospasm (DCV) after subarachnoid hemorrhage (SAH) was evaluated by repeated injections of recombinant streptokinase (r-SK)into lateral venticle in short period coupled with drainge of cerebral spinal fluid (CSF).
目的 :观察经侧脑室短期重复应用重组链激酶 (r SK)并引流脑脊液 ,对预防脑动脉瘤破裂蛛网膜下隙出血 (SAH)后迟发性脑血管痉挛 (DCV)的效果。
5) enterokinase light chain
肠激酶轻链
1.
Expression of recombinant mouse enterokinase light chain in E.coli;
重组鼠源性肠激酶轻链在大肠杆菌中的表达
6) single chain urokinase
单链尿激酶
1.
To obtain a thromblytic agent with high efficacy and specifity, we have engineered a recombinant chimeric plasminogen activator SZ51Hu scuPA, which was composed of a humanized monoclo nal antibody(SZ51Hu) directed against activated human platelets and a single chain urokinase(scuPA).
为了获得高效、高特异性溶栓药物，应用基因工程技术，成功的表达了由人源化抗人活化血小板单抗和单链尿激酶组成的抗体导向溶栓剂（ＳＺ５１Ｈｕ－ｓｃｕＰＡ）。
补充资料：链激酶
分子式：暂无
分子量：暂无
CAS号：9002-01-1
性质：暂无
制备方法：暂无
用途：酶类药。
分子量：暂无
CAS号：9002-01-1
性质：暂无
制备方法：暂无
用途：酶类药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条